Spor etiği bağlamında gen dopingi

Geçtiğimiz yüzyıldaki fizyoloji ve ilaçbilim alanlarında kaydedilen keşifler sporcuların, yarışma performanslarını arttırmak amacıyla doping kullanmalarını yaygınlaştırmış, hızlandırmıştır. Birçok atletin ölümüyle sonuçlanan skandallara ve etik problemlere rağmen bu sorun hala çözülmemiştir. Ortadankalkacağına, doping uygulamaları daha da kök salmakta ve performansı arttırmak için yeni doping yöntemleri bulunmaktadır. Bu yöntemlerin sonuncusu veşimdilik en gelişmiş olanı gen dopingidir. Bu çalışmanın amacı, gen dopinginin doğuracağı problemlere spor etiği açısından dikkat çekmektir. Çalışmadançıkacak sonuçlar şöyle özetlenebilir: Genetik mühendisliği henüz olgunlaşmamış bir alandır, bu yüzdengen dopingine başvuracak atletler kanser veya bağışıklık sistemi çökmesi gibi hastalıklardan muztarip olabilirler. Aynı zamanda, böyle pahalı bir teknolojiyeçoğunlukla varlıklı sporcular erişebileceklerdir. Dahası,dini inançlarından dolayı genetik müdahaleyi reddedensporcular, gen dopingli atletlerle yarışamayacaklardır.Bu da elit sporda adil bir yarışma imkânının ortadankalkacağı anlamına gelmektedir.

Gene doping in the context of ethics in sports

D iscoveries in the fields of physiology and pharmacology over the past hundred years have accelerated the wide-spread use of doping by individualathletes as a means of performance enhancement intheir sport. Despite the scandals that resulted in thedeaths of many athletes and the ethical questions,this issue is still unsolved. Rather than being eliminated, the practice of doping appears to have shifteddeeper underground, and illegitimated new methodsare still being found to improve performance. The latest and the most sophisticated one is called genedoping . The aim of this study is to call attention tothe problems of this latest doping method in the context of ethics in sports. The main results that havebeen drawn from this study can be summarized asfollows: Genetic engineering is still immature. There fore, the athletes resorting gene doping may be badlyharmed by cancer or immune system disorders. In addition, mostly, rich people will have opportunity to usethis expensive technology. Beside, the athletes who would refuse using gene doping in accordance with theirreligious beliefs may not contend with the gene-dopers.It means that the fair competition in elite sports maybe terminated.

PDF

___

Breivik G. (2005). Sport, gene doping and ethics. (CM Tamburrini, T Tännsjö,Eds.), Genetic Technology and Sport:Ethical Question (1st ed.), s. 165-177. New York: Routledge.
Brown WM. (1980). Ethics, drugs, and sport. Journal of The Philosophy of Sport, 7(1), 15-23.
Connor JM. (2009). Towards a sociology of drugs in sport. Sport in Society, 12(3), 327-343.
Friedmann T. (2010). How close are we to gene doping? Hastings Center Report 40, (2), 20-22.
Fukuyama F. (2003). İnsan Ötesi Geleceğimiz: Biyoteknoloji Devriminin Sonuçları. (Ç Aksoy Fromm Çev.). Ankara: Orta Doğu Teknik Üniversitesi.
Goldman B. (1992). Death in The Locker Room: Drugs and Sports. Chicago, IL: Elite Sports Publications.
Haisma HJ, de Hon O, Sollie P, Vorstenbosch J. (2004). Gene Doping. Netherland Centre for Doping Affairs:Topical Publication
Heimsoeth H. (1967). Immanuel Kantın Felsefesi. (T Mengüşoğlu Çev.). İstanbul: İstanbul.
Hemphill D. (2009). Performance enhancement and drug control in sport: Ethical considerations. Sport in Society, 12(3), 313-326.
Kuyurtar E. (2007). Ötenazinin ahlaksallığı. Felsefelogos, 1(32), 115-134.
Mazanov J, McDermott V. (2009). The case for a social science of drugs in sport. Sport in Society, 12(3), 276- 295.
Miah A. (2004). Genetically Modified Athletes Biomedical Ethics, Gene Doping and Sport. New York: Routledge.
Miah A. (2005). Gene doping: the shape of things to come. (C Tamburrini, T Tannsjo,Eds.). Genetic Technology and Sport: Ethical Question (1st ed.),s. 42-53. New York: Routledge.
Persson I. (2005). Whats wrong with admiring athletes and other people? (C Tamburrini, T Tannsjo,Eds.). Genetic Technology and Sport: Ethical Question (1st ed.),s. 70-81. New York: Routledge.
Schneider AJ. (2005). Genetic enhancement of athletic performance (CM Tamburrini, T Tännsjö, Eds.), Genetic Technology and Sport: Ethical Question (1st ed.), s. 32- 41. New York: Routledge.
Schneider AJ, Friedmann T. (2006). Gene Doping in Sports: The Science and Ethics of Genetically Modified Athletes. London, UK: Elsevier.
Schneider AJ, Rupert JL. (2009). Constructing winners: The science and ethics of genetically manipulating athletes. Journal of the Philosophy of Sport, 36, 182- 206.
Simon RL. (1984). Good competition and drug-enhanced performance. Journal of The Philosophy of Sport, 11(1), 6-13.
Tamburrini CM. (2000). Whats wrong with doping? (T Tännsjö, CM Tamburrini, Eds.), Values in sport: Elitism, Nationalism, Gender Equality and The Scientific Manufacture of Winners (1st ed.), s. 200-216. New York: Routledge.
Tamburrini CM. (2002). After doping, what? The morality of the genetic engineering of athletes. (WJ Morgan, Ed.). Ethics in Sport. (2nd ed.), s. 285-297. Champaign, IL: Human Kinetics.
Tamburrini CM. (2005). Educational or genetic blueprints, whats the difference? (CM Tamburrini, T Tännsjö, Eds.), Genetic Technology and Sport: Ethical Question (1st ed.), s. 83-90. New York: Routledge.
Tännsjö T. (2005). Genetic engineering and elitism in sport. (CM. Tamburrini, T. Tännsjö, Eds.), Genetic Technology and Sport: Ethical Question (1st ed.), s. 57-69. New York: Routledge.
WADA. (2003). International Standard for the Prohibited List 2004, 20 Mart 2009, http://www.wada-ama.org/ Documents/World_Anti-Doping_Program/WADPProhibited-list/WADA_Prohibited_List_2004_EN.pdf.
WADA. (2006). The Stockholm Declaration. Feature: Gene Doping Symposium. Play True, 1, s.22, 20 Şubat 2009, http://www.wada-ama.org/Documents/Science_ Medicine/Scientific%20Events/WADA_Stockholm_ Declaration_2005.pdf